Safety and effectiveness of a fixed-dose combination of olmesartan, amlodipine, and hydrochlorothiazide in clinical practice

  • Peter Bramlage, Eva-Maria Fronk, Wolf-Peter Wolf, Ruediger Smolnik, Gemma Sutton, Roland Schmieder
  • Vascular Health and Risk Management, December 2014, Taylor & Francis
  • DOI: 10.2147/vhrm.s75380

The authors haven't finished explaining this publication. If you are the author, sign in to claim or explain your work.

Read Publication

http://dx.doi.org/10.2147/vhrm.s75380

The following have contributed to this page: Peter Bramlage